BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

785 related articles for article (PubMed ID: 22808956)

  • 1. Genetically distinct subsets within ANCA-associated vasculitis.
    Lyons PA; Rayner TF; Trivedi S; Holle JU; Watts RA; Jayne DR; Baslund B; Brenchley P; Bruchfeld A; Chaudhry AN; Cohen Tervaert JW; Deloukas P; Feighery C; Gross WL; Guillevin L; Gunnarsson I; Harper L; Hrušková Z; Little MA; Martorana D; Neumann T; Ohlsson S; Padmanabhan S; Pusey CD; Salama AD; Sanders JS; Savage CO; Segelmark M; Stegeman CA; Tesař V; Vaglio A; Wieczorek S; Wilde B; Zwerina J; Rees AJ; Clayton DG; Smith KG
    N Engl J Med; 2012 Jul; 367(3):214-23. PubMed ID: 22808956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.
    Merkel PA; Xie G; Monach PA; Ji X; Ciavatta DJ; Byun J; Pinder BD; Zhao A; Zhang J; Tadesse Y; Qian D; Weirauch M; Nair R; Tsoi A; Pagnoux C; Carette S; Chung S; Cuthbertson D; Davis JC; Dellaripa PF; Forbess L; Gewurz-Singer O; Hoffman GS; Khalidi N; Koening C; Langford CA; Mahr AD; McAlear C; Moreland L; Seo EP; Specks U; Spiera RF; Sreih A; St Clair EW; Stone JH; Ytterberg SR; Elder JT; Qu J; Ochi T; Hirano N; Edberg JC; Falk RJ; Amos CI; Siminovitch KA;
    Arthritis Rheumatol; 2017 May; 69(5):1054-1066. PubMed ID: 28029757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Postgrad Med J; 2014 May; 90(1063):290-6. PubMed ID: 24737903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L31. A GWAS in ANCA-associated vasculitis: will genetics help re-define clinical classification?
    Lyons PA; Smith KG
    Presse Med; 2013 Apr; 42(4 Pt 2):589-91. PubMed ID: 23490642
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic variants in ANCA-associated vasculitis: a meta-analysis.
    Rahmattulla C; Mooyaart AL; van Hooven D; Schoones JW; Bruijn JA; Dekkers OM; ; Bajema IM
    Ann Rheum Dis; 2016 Sep; 75(9):1687-92. PubMed ID: 26443607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Ann Rheum Dis; 2013 Aug; 72(8):1273-9. PubMed ID: 23606701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of ANCA-associated vasculitides: HLA and beyond.
    Alberici F; Martorana D; Bonatti F; Gioffredi A; Lyons PA; Vaglio A
    Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S90-7. PubMed ID: 24854378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention.
    Kallenberg CG; Stegeman CA; Abdulahad WH; Heeringa P
    Am J Kidney Dis; 2013 Dec; 62(6):1176-87. PubMed ID: 23810690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management.
    Trivioli G; Marquez A; Martorana D; Tesi M; Kronbichler A; Lyons PA; Vaglio A
    Nat Rev Rheumatol; 2022 Oct; 18(10):559-574. PubMed ID: 36109667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathogenesis of ANCA-Associated Vasculitis.
    Kronbichler A; Lee KH; Denicolò S; Choi D; Lee H; Ahn D; Kim KH; Lee JH; Kim H; Hwang M; Jung SW; Lee C; Lee H; Sung H; Lee D; Hwang J; Kim S; Hwang I; Kim DY; Kim HJ; Cho G; Cho Y; Kim D; Choi M; Park J; Park J; Tizaoui K; Li H; Smith L; Koyanagi A; Jacob L; Gauckler P; Shin JI
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics and pathophysiology of granulomatosis with polyangiitis (GPA) and its main autoantigen proteinase 3.
    Relle M; Föhr B; Fasola F; Schwarting A
    Mol Cell Probes; 2016 Dec; 30(6):366-373. PubMed ID: 27559009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCA.
    Dahlqvist J; Ekman D; Sennblad B; Kozyrev SV; Nordin J; Karlsson Å; Meadows JRS; Hellbacher E; Rantapää-Dahlqvist S; Berglin E; Stegmayr B; Baslund B; Palm Ø; Haukeland H; Gunnarsson I; Bruchfeld A; Segelmark M; Ohlsson S; Mohammad AJ; Svärd A; Pullerits R; Herlitz H; Söderbergh A; Rosengren Pielberg G; Hultin Rosenberg L; Bianchi M; Murén E; Omdal R; Jonsson R; Eloranta ML; Rönnblom L; Söderkvist P; Knight A; Eriksson P; Lindblad-Toh K
    Rheumatology (Oxford); 2022 Aug; 61(8):3461-3470. PubMed ID: 34888651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of interleukin-32 and interleukin-6 in granulomatosis with polyangiitis and microscopic polyangiitis: association with clinical and biochemical findings.
    Krajewska Wojciechowska J; Kościelska-Kasprzak K; Krajewski W; Morawski K
    Eur Cytokine Netw; 2019 Dec; 30(4):151-159. PubMed ID: 32096477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct HLA and non-HLA associations in different subtypes of ANCA-associated vasculitides in North India.
    Singh J; Sharma A; Rani L; Kaur N; Anand S; Saikia B; Jha S; Nada R; Minz RW
    Int J Rheum Dis; 2020 Jul; 23(7):958-965. PubMed ID: 32297471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANCA-Associated Vasculitis: Core Curriculum 2020.
    Geetha D; Jefferson JA
    Am J Kidney Dis; 2020 Jan; 75(1):124-137. PubMed ID: 31358311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L32. ANCA vasculitis over the world. What do we learn from country differences?
    Watts RA; Scott DG
    Presse Med; 2013 Apr; 42(4 Pt 2):591-3. PubMed ID: 23481365
    [No Abstract]   [Full Text] [Related]  

  • 17. Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study.
    Kawasaki A; Hasebe N; Hidaka M; Hirano F; Sada KE; Kobayashi S; Yamada H; Furukawa H; Yamagata K; Sumida T; Miyasaka N; Tohma S; Ozaki S; Matsuo S; Hashimoto H; Makino H; Arimura Y; Harigai M; Tsuchiya N
    PLoS One; 2016; 11(5):e0154393. PubMed ID: 27166610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Effect of Alpha-1 Antitrypsin Deficiency in Antineutrophil Cytoplasmic Antibody-associated Vasculitis: Results from a French Retrospective Monocentric Cohort.
    Deshayes S; Martin Silva N; Grandhomme F; Khoy K; Mariotte D; Boutemy J; Maigné G; Brière-Bellier C; Delmas C; Bienvenu B; Lobbedez T; de Boysson H; Aouba A
    J Rheumatol; 2019 Nov; 46(11):1502-1508. PubMed ID: 30824651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomenclature and classification of vasculitis: lessons learned from granulomatosis with polyangiitis (Wegener's granulomatosis).
    Jennette JC
    Clin Exp Immunol; 2011 May; 164 Suppl 1(Suppl 1):7-10. PubMed ID: 21447122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic aspects of anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Alberici F; Martorana D; Vaglio A
    Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i37-45. PubMed ID: 25523449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.